CASI Pharmaceuticals annual gross profit
2020
2021
2022
2023
2024
2025
CASI Pharmaceuticals Gross Profit Growth & History (CASIF)
CASI Pharmaceuticals's gross profit was $10.1M for fiscal 2025.
View full CASI Pharmaceuticals company overviewCASI Pharmaceuticals annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $10.1M | −$1.1M | −9.60% |
| 2024 | 2024-12-31 | $11.1M | −$8.9M | −44.41% |
| 2023 | 2023-12-31 | $20.1M | −$7.2M | −26.50% |
| 2022 | 2022-12-31 | $27.3M | $9.7M | +54.90% |
| 2021 | 2021-12-31 | $17.6M | $12.0M | +212.64% |
| 2020 | 2020-12-31 | $5.6M | — | — |
CASI Pharmaceuticals gross profit trends
Over the last five fiscal years, CASI Pharmaceuticals's gross profit increased from $5.6M to $10.1M, a change of $4.4M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CASI Pharmaceuticals source filings ↗